EUVIMEDEUVIMED entdecken
Crossref

Map3k3 I441M Knock-In Mouse Model of Cerebral Cavernous Malformations

Hongyuan Xu, Yingxi Yang, Qiuxia Zhou, Ran Huo, Shaozhi Zhao, Yingfan Sun, Jie Wang, Qiheng He iD, Qifeng Yu iD, Jinyi Tang iD, Yuming Jiao iD, Jiguang Wang iD und 1 weitere

Stroke · 2025

DOI: 10.1161/strokeaha.124.049935 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stroke, 2025. Verfasst von Hongyuan Xu und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Beijing Tiantan Hospital (H.X., R.H., S.Z., Y.S., Jie Wang, Q.H., Q.Y., J.T., Y.J., Y.C.), Capital Medical University, Ch…. Hauptthemen laut MEDLINE: Hemangioma, Cavernous, Central Nervous System, MAP Kinase Kinase Kinase 3. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 36 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Cerebral cavernous malformations (CCMs) refer to vascular dysplasia primarily found in the brain, affecting ≈0.5% of the population. A somatic Map3k3 I441M mutation has been found in ≈40% of patients with sporadic CCMs, which were typically accompanied by somatic gain-of-function mutations in PIK3CA . Although mouse models of adeno-associated virus-BR1–mediated mutant overexpression have been reported, these models have limitations in representing clinical specimens of CCMs, which typically harbor single allele mutation in Map3k3 . A Map3k3 I441M knock-in murine model of CCMs has not yet been established. METHODS: The Map3k3 I441M knock-in mice were crossed with Cdh5 -creER T2 mice to induce mutant gene expression specifically in endothelial cells. Subsequently, Map3k3 I441M mice were bred with Pten fl/fl mice to generate Map3k3 I441M ; Pten fl/fl mice. In both murine models, CCM lesions were examined using magnetic resonance imaging, while single-cell RNA sequencing and immunostaining were utilized to investigate the pathomechanism of the mutation. Finally, we administered an mTOR (mechanistic target of rapamycin) inhibitor to explore its therapeutic effect on lesions of both murine models. RESULTS: Both endothelial Map3k3 I441M mutant juvenile mice and Map3k3 I441M ; Pten fl/fl mice developed abnormal lesions with human CCM characteristics. In Map3k3 I441M mice, the mutant promoted endothelial apoptosis, while activation of the PI3K (phosphatidylinositol 3-kinase) pathway was able to activate the downstream AKT (protein kinase B)/mTOR/p-S6 (phosphorylated S6 ribosomal protein) pathway and upregulate VEGFA (vascular endothelial growth factor A) expression, counteracting apoptosis, and facilitating lesion progression. The activation of PI3K signaling is required for Map3k3 I441M to generate CCM-like lesions in adult mice. Finally, we demonstrated that rapamycin effectively inhibited the formation of lesions in the Map3k3 I441M mice and Map3k3 I441M ; Pten fl/fl mice. CONCLUSIONS: Map3k3 I441M heterozygous is sufficient to induce lesions in juvenile mice, while the additional activation of PI3K signaling is required for the effective formation of CCMs at the adult stage. The Map3k3 I441M murine model provides a preclinical model for further mechanistic and therapeutic studies of CCMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hemangioma, Cavernous, Central Nervous SystemMAP Kinase Kinase Kinase 3AnimalsMiceDisease Models, AnimalGene Knock-In TechniquesMice, TransgenicTOR Serine-Threonine KinasesMutationPTEN Phosphohydrolase

Stichwörter der Autor:innen

disease models, animalhemangioma, cavernous, central nervous systemmutation

Substanzen

MAP Kinase Kinase Kinase 3TOR Serine-Threonine KinasesPTEN Phosphohydrolase

Autor:innen und Institutionen

  • Department of Neurosurgery, Beijing Tiantan Hospital (H.X., R.H., S.Z., Y.S., Jie Wang, Q.H., Q.Y., J.T., Y.J., Y.C.), Capital Medical University, China.
  • China National Clinical Research Center for Neurological Diseases, Beijing (H.X., R.H., S.Z., Y.S., Jie Wang, Q.H., Q.Y., J.T., Y.J., Y.C.).
  • Division of Life Science, Department of Chemical and Biological Engineering, and State Key Laboratory of Molecular Neuroscience, The Hong Kong University of Science and Technology, China (Y.Y., Q.Z., Jiguang Wang).
  • SIAT-HKUST Joint Laboratory of Cell Evolution and Digital Health, Shenzhen-Hong Kong Collaborative Innovation Research Institute, China (Jiguang Wang).
  • Beijing Neurosurgical Institute (Y.C.), Capital Medical University, China.

ORCID-Profile: Qiheng He, Qifeng Yu, Jinyi Tang, Yuming Jiao, Jiguang Wang, Yong Cao

Zitieren

APA

Xu, H., Yang, Y., Zhou, Q., Huo, R., Zhao, S., Sun, Y., Wang, J., He, Q., Yu, Q., Tang, J., Jiao, Y., Wang, J., & Cao, Y. (2025). Map3k3 I441M Knock-In Mouse Model of Cerebral Cavernous Malformations. Stroke. https://doi.org/10.1161/strokeaha.124.049935

Vancouver

Xu H, Yang Y, Zhou Q, Huo R, Zhao S, Sun Y, et al. Map3k3 I441M Knock-In Mouse Model of Cerebral Cavernous Malformations. Stroke. 2025. doi:10.1161/strokeaha.124.049935

BibTeX
@article{Xu2025,
  author = {Xu, Hongyuan and Yang, Yingxi and Zhou, Qiuxia and Huo, Ran and Zhao, Shaozhi and Sun, Yingfan and Wang, Jie and He, Qiheng and Yu, Qifeng and Tang, Jinyi and Jiao, Yuming and Wang, Jiguang and Cao, Yong},
  title = {Map3k3 I441M Knock-In Mouse Model of Cerebral Cavernous Malformations},
  journal = {Stroke},
  year = {2025},
  doi = {10.1161/strokeaha.124.049935}
}
Kostenlos starten →